These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma. Sandoval J; Díaz-Lagares A; Salgado R; Servitje O; Climent F; Ortiz-Romero PL; Pérez-Ferriols A; Garcia-Muret MP; Estrach T; Garcia M; Nonell L; Esteller M; Pujol RM; Espinet B; Gallardo F J Invest Dermatol; 2015 Apr; 135(4):1128-1137. PubMed ID: 25405321 [TBL] [Abstract][Full Text] [Related]
24. Immune function abnormalities in peripheral blood mononuclear cell cytokine expression differentiates stages of cutaneous T-cell lymphoma/mycosis fungoides. Chong BF; Wilson AJ; Gibson HM; Hafner MS; Luo Y; Hedgcock CJ; Wong HK Clin Cancer Res; 2008 Feb; 14(3):646-53. PubMed ID: 18245523 [TBL] [Abstract][Full Text] [Related]
25. Gene Expression Profiling of Mycosis Fungoides in Early and Tumor Stage-A Proof-of-Concept Study Using Laser Capture/Single Cell Microdissection and NanoString Analysis. Lai J; Li J; Gniadecki R; Lai R Cells; 2021 Nov; 10(11):. PubMed ID: 34831413 [TBL] [Abstract][Full Text] [Related]
26. Dysregulation of Plasma miR-146a and miR-155 Expression Profile in Mycosis Fungoides Is Associated with rs2910164 and rs767649 Polymorphisms. Avgeros C; Patsatsi A; Dimitriadis D; Malousi A; Koletsa T; Papathemeli D; Syrnioti A; Avgerou P; Lazaridou E; Tzimagiorgis G; Georgiou E Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613718 [TBL] [Abstract][Full Text] [Related]
27. A meta-analysis of gene expression data identifies a molecular signature characteristic for tumor-stage mycosis fungoides. van Kester MS; Borg MK; Zoutman WH; Out-Luiting JJ; Jansen PM; Dreef EJ; Vermeer MH; van Doorn R; Willemze R; Tensen CP J Invest Dermatol; 2012 Aug; 132(8):2050-9. PubMed ID: 22513784 [TBL] [Abstract][Full Text] [Related]
28. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides. Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425 [TBL] [Abstract][Full Text] [Related]
30. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969 [TBL] [Abstract][Full Text] [Related]
31. Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome. Whittaker SJ; Smith NP; Jones RR; Luzzatto L Cancer; 1991 Oct; 68(7):1572-82. PubMed ID: 1654197 [TBL] [Abstract][Full Text] [Related]
32. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi. Sand M; Skrygan M; Sand D; Georgas D; Gambichler T; Hahn SA; Altmeyer P; Bechara FG Cell Tissue Res; 2013 Jan; 351(1):85-98. PubMed ID: 23111773 [TBL] [Abstract][Full Text] [Related]
33. Determination of T-cell clonality and expression profiles of Toll-like receptors signaling pathway genes and related miRNAs in patients with mycosis fungoides. Seçme M; Dodurga Y; Demirkan NÇ; Kaçar N; Günel NS; Açıkbaş İ Gene; 2024 Jan; 891():147825. PubMed ID: 37748629 [TBL] [Abstract][Full Text] [Related]
34. miR-223 regulates cell growth and targets proto-oncogenes in mycosis fungoides/cutaneous T-cell lymphoma. McGirt LY; Adams CM; Baerenwald DA; Zwerner JP; Zic JA; Eischen CM J Invest Dermatol; 2014 Apr; 134(4):1101-1107. PubMed ID: 24304814 [TBL] [Abstract][Full Text] [Related]
35. TOX expression in different subtypes of cutaneous lymphoma. Morimura S; Sugaya M; Suga H; Miyagaki T; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S Arch Dermatol Res; 2014 Nov; 306(9):843-9. PubMed ID: 25216799 [TBL] [Abstract][Full Text] [Related]
36. Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome. Nguyen GH; Olson LC; Magro CM Ann Diagn Pathol; 2017 Jun; 28():54-59. PubMed ID: 28648940 [TBL] [Abstract][Full Text] [Related]